Does antenatal magnesium sulphate improve hearing function in premature newborns?
- Resource Type
- Authors
- Salih Çağrı Çakır; Isil Kasapoglu; Kemal Özerkan; Rabia Tütüncü Toker; Bilge Çetinkaya Demir; Adnan Orhan; Hilal Özkan; Fikret Kasapoglu; Mehmet Aral Atalay
- Source
- Journal of the Turkish-German Gynecological Association, Vol 21, Iss 3, Pp 187-192 (2020)
Journal of the Turkish German Gynecological Association
- Subject
- Continuous infusion
lcsh:Medicine
Betamethasone
0302 clinical medicine
Corticosteroid
Obstetrics & gynecology
Original Investigation
Hearing screening
Obstetrics
Obstetrics and Gynecology
Gestational age
Electroencephalography
University hospital
Neuroprotection
Retrospective study
Premature newborn
Microcephaly
Female
Cohort analysis
Prematurity
Infants
Eclampsia
Magnesium Sulfate
Pregnancy Toxemia
Magnesium sulfate
medicine.drug
Human
Adult
medicine.medical_specialty
Auditory brain stem implantation
Hemorrhage
Major clinical study
Courses
lcsh:Gynecology and obstetrics
Article
Hearing impairment
03 medical and health sciences
Neonatal intensive care unit
030225 pediatrics
otorhinolaryngologic diseases
medicine
Apgar score
lcsh:RG1-991
business.industry
lcsh:R
Loading drug dose
Magnesium sulphate
Infant
Retrospective cohort study
Hearing loss
Premature fetus membrane rupture
medicine.disease
Ototoxicity
Newborn
Preeclampsia
Auditory brainstem response
Clinical feature
Birth
Small for gestational age
Hearing function
business
Cesarean section
030217 neurology & neurosurgery
- Language
- English
Objective: To evaluate whether antenatal magnesium sulphate (MgSO4) exposure has a neuroprotective effect against hearing impairment in premature newborns. Material and Methods: Retrospective cohort study was performed with prematurely (